CASI: CASI Pharmaceuticals, Inc. Stock

by  •  • Comments Off on CASI: CASI Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 34.70
Enterprise Value ($M) 37.29
Book Value ($M) 13.85
Book Value / Share 0.89
Price / Book 2.51
NCAV ($M) -2.62
NCAV / Share -0.17
Price / NCAV -13.26

Profitability (mra)
Return on Invested Capital (ROIC) -0.94
Return on Assets (ROA) -0.41
Return on Equity (ROE) -1.28

Liquidity (mrq)
Quick Ratio 2.32
Current Ratio 3.20

Balance Sheet (mrq) ($M)
Current Assets 47.15
Assets 63.62
Liabilities 49.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-03 13D/A Idg-accel China Growth Fund Iii L.p. 6.40
10-29 13G/A Huang James 9.20 26.99
08-12 13D/A He Wei-Wu 20.94 14.80
07-25 13G Venrock Healthcare Capital Partners III, L.P. 9.99
06-20 13G Foresite Capital Fund VI LP 9.80
2024-02-20 13D/A Sparkle Byte Ltd 7.60 -90.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 332 2,518 13.19
2025-03-10 694 4,730 14.67
2025-03-07 368 2,878 12.79
2025-03-06 2,897 11,979 24.18

(click for more detail)

Similar Companies
CALC – CalciMedica, Inc. CAPR – Capricor Therapeutics, Inc.
CARA – Cara Therapeutics, Inc. CDIO – Cardio Diagnostics Holdings, Inc.
CDTX – Cidara Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io